Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (6.098%)
Market Cap: £70.16m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Directorate Change

29 Nov 2018 10:37

RNS Number : 9093I
Maven Income & Growth VCT PLC
29 November 2018
 

Maven Income and Growth VCT PLC (the Company)

 

Directorate Changes

 

As announced on 26 September 2018, alongside the publication of the Prospectus for the Offer for Subscription, the Board now confirms that Fiona Wollocombe will resign as a Non-executive Director of the Company with effect from 24 January 2019. Mrs Wollocombe has been a Director of the Company since 20 May 2004, serving as its Chairman from 7 July 2005 until 8 July 2010, and the Board wishes to record its gratitude for the significant contribution Fiona made during her time in office and extends to her its best wishes for the future.

 

The Board is also pleased to announce the appointments of Dr Alison Fielding and Dr Andrew Harrington as Non-executive Directors, each with effect from 1 January 2019. Both of these new Directors will also serve on the Company's Audit, Management Engagement, Nomination, Risk and Remuneration Committees, and will stand for election by Shareholders at the Annual General Meeting to be held in July 2019

 

Dr Fielding is an experienced entrepreneur, senior executive and non-executive director, with a track record of leading strategy within both large and small organisations to set direction, evaluate options, implement plans and drive performance. She is currently a venture partner at IP Group plc, with her role there including two non-executive directorships with portfolio companies; Perachem Holdings plc, of which she is chairman, and Getech Group plc, where she chairs the audit committee.

 

Alison has held a number of other non-executive roles and her other current appointments include non-executive directorships of Nanoco Group plc and Queen Mary Innovation Limited, and serving as a trustee of the Royal Voluntary Service and the Carnegie Trust for the Universities of Scotland.

 

Dr Harrington is co-owner of AHV Associates LLP, which was formed in 2001 and works alongside management teams and shareholders across many sectors to advise on transactions, such as the purchase or sale of companies and capital raising.

 

Andrew was previously founder and chief executive of Nextcall Telecom, a business backed by venture and private investor capital, before which he was managing director at Salomon Brothers, where he advised on investment, IPOs, secondary public market offerings and mergers & acquisitions.

 

In relation to both of these new appointments, there is no additional information required to be disclosed pursuant to Listing Rule 9.6.13 R.

 

Maven Capital Partners UK LLP

Secretary

29 November 2018

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAPGGQWGUPRGUB
Date   Source Headline
27th Oct 20151:15 pmRNSHalf Yearly Report
9th Oct 201510:43 amRNSStatement re Net Asset Value and Interim Dividend
24th Aug 20153:33 pmRNSStatement re Dividend Investment Scheme
17th Jul 20154:33 pmRNSIssue of Equity
17th Jul 201510:42 amRNSNet Asset Value(s)
9th Jul 20154:23 pmRNSNet Asset Value(s)
9th Jul 20154:16 pmRNSDirectorate Change
9th Jul 20154:11 pmRNSResult of AGM
5th Jun 20154:35 pmRNSAnnual Financial Report
6th May 20152:26 pmRNSStatement re NAV & Proposed Dividend Declaration
13th Apr 20153:08 pmRNSIssue of Equity
27th Mar 20154:46 pmRNSDirector/PDMR Shareholding
27th Mar 20154:45 pmRNSDirector/PDMR Shareholding
27th Mar 20154:45 pmRNSDirector/PDMR Shareholding
20th Mar 20154:52 pmRNSIssue of Equity
26th Feb 201512:09 pmRNSIssue of Equity
26th Feb 201510:41 amRNSDirector/PDMR Shareholding
26th Feb 201510:38 amRNSDirector/PDMR Shareholding
26th Feb 201510:38 amRNSDirector/PDMR Shareholding
20th Feb 20152:44 pmRNSIssue of Equity
5th Feb 20155:00 pmRNSStatement re Offers for Subscription
3rd Feb 20153:07 pmRNSStatement re Offers for Subscription
30th Jan 20154:53 pmRNSStatement re Offers for Subscription
28th Jan 20152:21 pmRNSNet Asset Value(s)
21st Jan 20153:47 pmRNSStatement re Offers and Related Party Transactions
20th Jan 20159:48 amRNSStatement re Offers for Subscription
7th Jan 20152:11 pmRNSStatement re Offers for Subscription
28th Nov 20144:22 pmRNSTransaction in Own Shares
28th Oct 20147:00 amRNSHalf Yearly Report
20th Oct 20146:27 pmRNSStatement re Prospectus and Circular
10th Oct 20149:57 amRNSNet Asset Value(s)
3rd Oct 20144:20 pmRNSTotal Voting Rights
1st Oct 201410:50 amRNSStatement re Joint Offer for Subscription
5th Aug 20144:05 pmRNSTransaction in Own Shares
4th Aug 20144:28 pmRNSTransaction in Own Shares
31st Jul 20143:51 pmRNSTransaction in Own Shares
11th Jul 20142:46 pmRNSInterim Management Statement
10th Jul 20142:06 pmRNSResult of AGM
4th Jul 20144:28 pmRNSReplacement re Issue of Equity
2nd Jul 20149:45 amRNSIssue of Equity
6th Jun 20144:48 pmRNSAnnual Financial Report
28th May 20145:07 pmRNSOffer for Subscription Update
21st May 20149:55 amRNSNet Asset Value(s)
30th Apr 20147:01 amRNSStatement re Offer for Subscription
24th Apr 20142:43 pmRNSOffer for Subscription - Supplementary Prospectus
7th Apr 20144:11 pmRNSOffer for Subscription - Supplementary Prospectus
7th Apr 201411:27 amRNSIssue of Equity
18th Mar 20147:00 amRNSOffer for Subscription - Supplementary Prospectus
17th Feb 201412:31 pmRNSDirector/PDMR Shareholding
10th Feb 20146:02 pmRNSOffer for Subscription - Supplementary Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.